
In 2012, Ceapro anticipates expanding manufacturing capacity to allow us to meet our customers increasing demands for our ingredients, and our goal to produce several new products. Facility options are currently being assessed.
Ceapro plans to construct a Pressurized Green Solvent (PGS) plant within the next two years should favourable economic conditions prevail. This state-of-the-art facility will allow Ceapro to produce new and innovative products as well as incorporating a new downstream bio-chromatographic purification system. These innovative process technologies allow Ceapro to produce bio-actives for the nutraceutical and pharmaceutical markets.